| Jenna Alysse Bernstein, MD | |
|
888 White Plains Rd Ste 105&106, Trumbull, CT 06611-4552 | |
| (203) 268-2882 | |
| (203) 452-3099 |
| Full Name | Jenna Alysse Bernstein |
|---|---|
| Gender | Female |
| Speciality | Orthopedic Surgery |
| Experience | 10 Years |
| Location | 888 White Plains Rd Ste 105&106, Trumbull, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689093775 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 65013 (Connecticut) | Secondary |
| 207XS0114X | Orthopaedic Surgery - Adult Reconstructive Orthopaedic Surgery | 65013 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St. Vincent's Medical Center | Bridgeport, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Connecticut Orthopaedic Specialists Pc | 7315850039 | 154 |
| Ptsma Inc | 7911800180 | 92 |
| Rehabilitation Associates Inc | 8022905322 | 297 |
News Archive
Non-Alcoholic Fatty Liver Disease, which is not caused by significant alcohol consumption, has become the most common liver disease in the United States and comprises more than two thirds of patients with chronic liver disease.
iiBIG and the newly formed Global Biopharmaceutical Advisory Board have jointly planned an event that will focus on one of the most dynamic trends in the pharmaceutical, biotechnology, and medical device industries - strategic outsourcing. Biopharma CEOs, VPs of Global Operations, and Department Heads will meet at the 4th Annual Global Clinical Trial Partnerships, March 1-2, 2010, in Princeton, New Jersey to discuss the latest strategies for optimizing global operations.
An international research group headed by scientists from Helmholtz Zentrum München has developed a method for calculating the risk for developing type 1 diabetes that is significantly superior to earlier methods.
All diseases have a genetic component. Advances in understanding the genetic mechanisms behind these disease enables the development of early diagnostic tests, new treatments, or interventions to prevent disease onset or minimize disease severity.
› Verified 7 days ago
| Entity Name | Yale University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205822236 PECOS PAC ID: 9436061736 Enrollment ID: O20031105000015 |
News Archive
Non-Alcoholic Fatty Liver Disease, which is not caused by significant alcohol consumption, has become the most common liver disease in the United States and comprises more than two thirds of patients with chronic liver disease.
iiBIG and the newly formed Global Biopharmaceutical Advisory Board have jointly planned an event that will focus on one of the most dynamic trends in the pharmaceutical, biotechnology, and medical device industries - strategic outsourcing. Biopharma CEOs, VPs of Global Operations, and Department Heads will meet at the 4th Annual Global Clinical Trial Partnerships, March 1-2, 2010, in Princeton, New Jersey to discuss the latest strategies for optimizing global operations.
An international research group headed by scientists from Helmholtz Zentrum München has developed a method for calculating the risk for developing type 1 diabetes that is significantly superior to earlier methods.
All diseases have a genetic component. Advances in understanding the genetic mechanisms behind these disease enables the development of early diagnostic tests, new treatments, or interventions to prevent disease onset or minimize disease severity.
› Verified 7 days ago
| Entity Name | Connecticut Orthopaedic Specialists Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235181389 PECOS PAC ID: 7315850039 Enrollment ID: O20031110000220 |
News Archive
Non-Alcoholic Fatty Liver Disease, which is not caused by significant alcohol consumption, has become the most common liver disease in the United States and comprises more than two thirds of patients with chronic liver disease.
iiBIG and the newly formed Global Biopharmaceutical Advisory Board have jointly planned an event that will focus on one of the most dynamic trends in the pharmaceutical, biotechnology, and medical device industries - strategic outsourcing. Biopharma CEOs, VPs of Global Operations, and Department Heads will meet at the 4th Annual Global Clinical Trial Partnerships, March 1-2, 2010, in Princeton, New Jersey to discuss the latest strategies for optimizing global operations.
An international research group headed by scientists from Helmholtz Zentrum München has developed a method for calculating the risk for developing type 1 diabetes that is significantly superior to earlier methods.
All diseases have a genetic component. Advances in understanding the genetic mechanisms behind these disease enables the development of early diagnostic tests, new treatments, or interventions to prevent disease onset or minimize disease severity.
› Verified 7 days ago
| Entity Name | Hartford Healthcare Medical Group Specialists Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023584216 PECOS PAC ID: 3173866241 Enrollment ID: O20190514001441 |
News Archive
Non-Alcoholic Fatty Liver Disease, which is not caused by significant alcohol consumption, has become the most common liver disease in the United States and comprises more than two thirds of patients with chronic liver disease.
iiBIG and the newly formed Global Biopharmaceutical Advisory Board have jointly planned an event that will focus on one of the most dynamic trends in the pharmaceutical, biotechnology, and medical device industries - strategic outsourcing. Biopharma CEOs, VPs of Global Operations, and Department Heads will meet at the 4th Annual Global Clinical Trial Partnerships, March 1-2, 2010, in Princeton, New Jersey to discuss the latest strategies for optimizing global operations.
An international research group headed by scientists from Helmholtz Zentrum München has developed a method for calculating the risk for developing type 1 diabetes that is significantly superior to earlier methods.
All diseases have a genetic component. Advances in understanding the genetic mechanisms behind these disease enables the development of early diagnostic tests, new treatments, or interventions to prevent disease onset or minimize disease severity.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jenna Alysse Bernstein, MD 2408 Whitney Ave, Hamden, CT 06518-3209 Ph: (203) 626-0160 | Jenna Alysse Bernstein, MD 888 White Plains Rd Ste 105&106, Trumbull, CT 06611-4552 Ph: (203) 268-2882 |
News Archive
Non-Alcoholic Fatty Liver Disease, which is not caused by significant alcohol consumption, has become the most common liver disease in the United States and comprises more than two thirds of patients with chronic liver disease.
iiBIG and the newly formed Global Biopharmaceutical Advisory Board have jointly planned an event that will focus on one of the most dynamic trends in the pharmaceutical, biotechnology, and medical device industries - strategic outsourcing. Biopharma CEOs, VPs of Global Operations, and Department Heads will meet at the 4th Annual Global Clinical Trial Partnerships, March 1-2, 2010, in Princeton, New Jersey to discuss the latest strategies for optimizing global operations.
An international research group headed by scientists from Helmholtz Zentrum München has developed a method for calculating the risk for developing type 1 diabetes that is significantly superior to earlier methods.
All diseases have a genetic component. Advances in understanding the genetic mechanisms behind these disease enables the development of early diagnostic tests, new treatments, or interventions to prevent disease onset or minimize disease severity.
› Verified 7 days ago
David Jon Martin, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 888 White Plains Rd Ste 106, Trumbull, CT 06611 Phone: 203-268-2882 Fax: 203-601-8585 | |
Dr. Curtis Lyle Campbell, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 888 White Plains Rd Ste 106, Trumbull, CT 06611 Phone: 203-268-2882 Fax: 203-452-3099 | |
Peter Stuart Boone, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 888 White Plains Rd Ste 106, Trumbull, CT 06611 Phone: 203-268-2882 Fax: 203-601-8551 | |
Kelms Amoo-achampong, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 888 White Plains Rd Ste 105&106, Trumbull, CT 06611 Phone: 203-268-2882 Fax: 203-452-3099 | |
Dr. Michael R Redler, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 888 White Plains Rd Ste 106, Trumbull, CT 06611 Phone: 203-268-2882 Fax: 203-445-5572 | |
John V Mangieri, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 160 Hawley Lane, Trumbull, CT 06611 Phone: 203-381-9670 Fax: 203-381-9669 | |
Dr. Alim Ramji, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 888 White Plains Rd Ste 105&106, Trumbull, CT 06611 Phone: 203-268-2882 Fax: 203-452-3099 |